Schedule 13D ownership disclosure

HTG MOLECULAR DIAGNOSTICS, INC

Security class unavailable · CUSIP: 40434H104

Event date: 2015-05-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,092,781
Percent of class
16.1200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000903423-15-000333
Form type
SC 13D
Filer
GSK plc
CIK
CIK 1131399
Filed
May 15, 2015
Reporting period
May 05, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub